Skip to content

Sodium phosphate tablets versus 4L PEG solution as bowel cleansing for colonoscopy

Randomized controlled trial of sodium phosphate tablets versus 4L PEG solution as bowel cleansing for colonoscopy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0000724
Enrollment
360
Registered
2013-04-22
Start date
2012-12-03
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(bowel cleasing agent for colonoscopy) : The enrolled patients undergoing morning colonoscopy will be randomized to either NaP tablets (32 tablets) or PEG solution (4L)

Sponsors

Kangbuk Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. 19 = age = 60 2. patients without renal failure 3. outpatients

Exclusion criteria

Exclusion criteria: 1.age60 2.patients with renal failure 3.inpatients

Design outcomes

Primary

MeasureTime frame
bowel clean efficacy

Secondary

MeasureTime frame
patients compliance

Countries

Korea, Republic of

Contacts

Public ContactYoon Suk Jung

Kangbuk Samsung Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026